You have 9 free searches left this month | for more free features.

sham

Showing 26 - 50 of 62

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Knee Arthroplasty Trial in Kingston (Magnesium Sulfate, Ropivacaine, Sham)

Completed
  • Knee Arthroplasty
  • Magnesium Sulfate
  • +2 more
  • Kingston, Ontario, Canada
  • +1 more
Nov 10, 2020

Diabetic Retinopathy Trial in Cleveland (Aflibercept, Sham)

Completed
  • Diabetic Retinopathy
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
May 12, 2020

Knee Osteoarthritis Trial in United States (SM04690, Placebo, Sham)

Completed
  • Knee Osteoarthritis
  • Anniston, Alabama
  • +73 more
May 20, 2021

Macular Edema Trial in Beijing (700 µg Dexamethasone, Sham)

Completed
  • Macular Edema
  • 700 μg Dexamethasone
  • Sham
  • Beijing, China
    (unnamed)
Apr 9, 2019

Reperfusion Injuries, Myocardial Trial (drug, biological, other)

Completed
  • Reperfusion Injuries, Myocardial
  • Dimethyl Malonate
  • +3 more
  • (no location specified)
Jun 6, 2019

Geographic Atrophy Trial in United States (Sham, Lampalizumab)

Completed
  • Geographic Atrophy
  • Mesa, Arizona
  • +35 more
Sep 23, 2019

Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

Active, not recruiting
  • Geographic Atrophy
  • Macular Degeneration
  • Beverly Hills, California
  • +208 more
Sep 14, 2021

Choroidal Neovascularization, Age-Related Maculopathy Trial in Worldwide (drug, biological, other)

Completed
  • Choroidal Neovascularization
  • Age-Related Maculopathy
  • Boynton Beach, Florida
  • +8 more
Apr 11, 2019

Abortion Late, Pain Trial in San Diego (procedure, behavioral, drug)

Terminated
  • Abortion Late
  • Pain
  • Local anesthetic for tenaculum placement
  • +5 more
  • San Diego, California
  • +1 more
May 21, 2019

Nonproliferative Diabetic Retinopathy Trial in Worldwide (Intravitreal aflibercept injection [IAI], Sham)

Completed
  • Nonproliferative Diabetic Retinopathy
  • Intravitreal aflibercept injection [IAI]
  • Sham
  • Phoenix, Arizona
  • +88 more
Jul 15, 2020

Macular Edema Secondary to Retinal Vein Occlusion Trial in Worldwide (Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose,

Not yet recruiting
  • Macular Edema Secondary to Retinal Vein Occlusion
  • Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
  • +3 more
  • Fullerton, California
  • +311 more
Apr 28, 2023

Pulmonary Embolism Trial in Indianapolis, Jackson (Inhaled Nitric Oxide, Sham)

Completed
  • Pulmonary Embolism
  • Inhaled Nitric Oxide
  • Sham
  • Indianapolis, Indiana
  • +3 more
Sep 6, 2018

Geographic Atrophy Trial in Worldwide (Lampalizumab, Sham)

Terminated
  • Geographic Atrophy
  • Birmingham, Alabama
  • +144 more
Jun 17, 2019

Dry Eye Syndromes Trial in United States (Vehicle, Sham, Cyclosporine New Ophthalmic Formulation)

Terminated
  • Dry Eye Syndromes
  • Artesia, California
  • +7 more
Apr 12, 2018

Sleep Apnea Trial in Boston (Inspired oxygen (40%), Sham)

Completed
  • Sleep Apnea
  • Inspired oxygen (40%)
  • Sham
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 19, 2018

Proliferative Diabetic Retinopathy Trial in Guangzhou (ranibizumab, sham, pars plana vitrectomy)

Completed
  • Proliferative Diabetic Retinopathy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Oct 12, 2017

Phantom Limb Pain (PLP), Primary/Secondary Scar Hyperalgesia Trial in Brussels (Lidocaine, Sham)

Withdrawn
  • Phantom Limb Pain (PLP)
  • Primary/Secondary Scar Hyperalgesia
  • Brussels, Belgium
  • +1 more
Jan 18, 2018

Geographic Atrophy, Macular Degeneration Trial in Worldwide (400 µg Brimonidine Implant, Sham)

Terminated
  • Geographic Atrophy
  • Macular Degeneration
  • 400 µg Brimonidine Implant
  • Sham
  • Phoenix, Arizona
  • +40 more
Mar 29, 2019

Chronic Sinusitis, Nasal Polyposis Trial in United States (S8 Sinus Implant, Mometasone furoate nasal spray, Sham)

Completed
  • Chronic Sinusitis
  • Nasal Polyposis
  • S8 Sinus Implant
  • +2 more
  • Birmingham, Alabama
  • +39 more
Jul 18, 2018

Choroidal Neovascularization, Uveitis Trial (Conbercept, sham)

Unknown status
  • Choroidal Neovascularization
  • Uveitis
  • (no location specified)
Oct 13, 2016

Otitis Media With Effusion Trial in San Diego (OTO-201, Sham)

Completed
  • Otitis Media With Effusion
  • San Diego, California
    Call/email Otonomy Central Contact for Trial Locations
Sep 23, 2016

Geographic Atrophy Trial in Germany, United States (FCFD4514S, sham)

Completed
  • Geographic Atrophy
  • Tucson, Arizona
  • +35 more
Nov 1, 2016

Diabetic Macular Edema (DME) Trial in United States (AKB-9778, ranibizumab, Placebo)

Completed
  • Diabetic Macular Edema (DME)
  • Pheonix, Arizona
  • +38 more
Mar 15, 2017

Otitis Media With Effusion Trial in San Diego (OTO-201, Sham)

Completed
  • Otitis Media With Effusion
  • San Diego, California
    Call/email Otonomy Central Contact for Trial Locations
May 9, 2016

Diabetic Macular Edema Trial in Vienna (Bevacizumab (Avastin), Triamcinolone, Sham)

Completed
  • Diabetic Macular Edema
  • Bevacizumab (Avastin)
  • +3 more
  • Vienna, Austria
    Dept. of Ophthalmology, Medical University of Vienna
Mar 3, 2016